Literature DB >> 25852814

Nonalcoholic Fatty liver disease and psoriasis: what a dermatologist needs to know.

Ronald Prussick1, Lisa Prussick2, Dillon Nussbaum3.   

Abstract

Psoriasis is a systemic inflammatory disease associated with a variety of comorbidities. It has been shown that psoriasis patients have an increased incidence of nonalcoholic fatty liver disease over controls. Patients with nonalcoholic fatty liver disease and psoriasis have more severe skin disease and are at higher risk of severe liver fibrosis than patients without psoriasis. The authors will review the diagnosis of nonalcoholic fatty liver disease and also discuss lifestyle changes and treatments for psoriasis that may benefit or worsen nonalcoholic fatty liver disease.

Entities:  

Year:  2015        PMID: 25852814      PMCID: PMC4382145     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  16 in total

1.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

Review 2.  Benefits of lifestyle modification in NAFLD.

Authors:  Stephen A Harrison; Christopher Paul Day
Journal:  Gut       Date:  2007-10-02       Impact factor: 23.059

3.  Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

Authors:  Luca Miele; Selenia Vallone; Consuelo Cefalo; Giuseppe La Torre; Carmine Di Stasi; Fabio M Vecchio; Magda D'Agostino; Maria L Gabrieli; Vittoria Vero; Marco Biolato; Maurizio Pompili; Giovanni Gasbarrini; Gianludovico Rapaccini; Pierluigi Amerio; Clara De Simone; Antonio Grieco
Journal:  J Hepatol       Date:  2009-06-26       Impact factor: 25.083

4.  High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.

Authors:  Ylse Gutiérrez-Grobe; Norberto Chávez-Tapia; Vicente Sánchez-Valle; Juan Gabriel Gavilanes-Espinar; Guadalupe Ponciano-Rodríguez; Misael Uribe; Nahum Méndez-Sánchez
Journal:  Ann Hepatol       Date:  2012 May-Jun       Impact factor: 2.400

5.  The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.

Authors:  Shraddha Madanagobalane; Sankarasubramanian Anandan
Journal:  Australas J Dermatol       Date:  2012-06-06       Impact factor: 2.875

6.  The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

Authors:  A Campanati; G Ganzetti; A Di Sario; A Damiani; L Sandroni; L Rosa; A Benedetti; A Offidani
Journal:  J Gastroenterol       Date:  2012-10-13       Impact factor: 7.527

7.  Drug use and toxicity in psoriatic disease: focus on methotrexate.

Authors:  William J Taylor; Eleanor Korendowych; Peter Nash; Philip S Helliwell; Ernest Choy; Gerald G Krueger; Enrique R Soriano; Neil J McHugh; Cheryl F Rosen
Journal:  J Rheumatol       Date:  2008-07       Impact factor: 4.666

8.  Meta-analysis: vitamin D and non-alcoholic fatty liver disease.

Authors:  M Eliades; E Spyrou; N Agrawal; M Lazo; F L Brancati; J J Potter; A A Koteish; J M Clark; E Guallar; R Hernaez
Journal:  Aliment Pharmacol Ther       Date:  2013-06-20       Impact factor: 8.171

Review 9.  Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  Aliment Pharmacol Ther       Date:  2010-12-29       Impact factor: 8.171

10.  Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?

Authors:  Aibek E Mirrakhimov; Vsevolod Y Polotsky
Journal:  Front Neurol       Date:  2012-10-17       Impact factor: 4.003

View more
  5 in total

1.  Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease.

Authors:  Hong-Jue Li; Chang-Ping Li; Chao Zhang; Xiao-Lin Zhong; Lei Shi
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study.

Authors:  Vikram K Mahajan; Narvir S Chauhan; Baldev S Rana; Karaninder S Mehta; Sheenam Hooda; Pushpinder S Chauhan; Amisha Kukreja
Journal:  J Clin Exp Hepatol       Date:  2021-12-03

Review 3.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

4.  The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients.

Authors:  Carmen Daniela Neagoe; Anca Smaranda Farmazon; Anca Maria Amzolini; Cristina Elena Singer; Simona Laura Ianoşi; Cristina Violeta Tutunaru; Amelia Valentina Genunche-Dumitrescu; Nicolae Gabriel Ianoşi; Ion Păun; Polliana Mihaela Leru; Oana Sorina Tica; Mihaela Popescu
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

Review 5.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.

Authors:  Deepak M W Balak; Stefano Piaserico; Ismail Kasujee
Journal:  Psoriasis (Auckl)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.